zepbound or semaglutide beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs – Can Zepbound Outperform Wegovy and
Description
The triple-agonist mechanism does not appear to produce dramatically worse stomach pain than single-agonist GLP-1 compounds

After your first month of treatment, the Precision Peptide Genetic Test ($99 add-on) reveals your peptide pathway genetics and helps your PlexusDx provider fine-tune your dose and monitor your response

Wegovys effects on fertility and pregnancy underscore the need for medical professionals to equip patients with comprehensive information to make informed decisions
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Diabetes-induced reduction in BDNF secretion, along with increased receptor for advanced glycation end products (RAGE), contributes to cerebrovascular dysfunction and cognitive decline (Kim and Song, 2020)

The most common side effects are mild nausea, constipation, and diarrhea, especially during the first few weeks

Both medications have demonstrated excellent results, but semaglutide remains a trusted option for individuals who prioritize a proven, steady approach to weight management
